Search in:

Advanced search

Current Medical Research and Opinion Volume 34, 2018 - Issue 7

Submit an article Journal homepage

Free access

1,814

Views

CrossRef citations to date

Altmetric

Professional

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014

Bryan R. Deanea Livewire Editorial Communications, Gerrards Cross, Bucks, UK; Correspondence[email protected]

Sheuli Porkessb Association of the British Pharmaceutical Industry, London, UK

Pages 1239-1243 | Received 01 Aug 2017, Accepted 05 Dec 2017, Published online: 05 Jan 2018

Cite this article
https://doi.org/10.1080/03007995.2017.1415057
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions
View PDF PDF

Supplemental material

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014

Supplemental Material - Zydelig

Supplemental Material - Vimizim

Supplemental Material - Velphoro

Supplemental Material - Vargatef

Supplemental Material - Trulicity

Supplemental Material - Translarna

Supplemental Material - Tivicay

Supplemental Material - Tecfidera

Supplemental Material - Sylvant

Supplemental Material - Sovaldi

Supplemental Material - Sirturo

Supplemental Material - Scenesse

Supplemental Material - Rixubris

Supplemental Material - Plegridy

Supplemental Material - Olysio

Supplemental Material - Nuwiq

Supplemental Material - Moventig

Supplemental Material - Mekinist

Supplemental Material - Lynparza

Supplemental Material - Latuda

Supplemental Material - Jardiance

Supplemental Material - Incruse

Supplemental Material - Imbruvica

Supplemental Material - Harvoni

Supplemental Material - Gazyvaro

Supplemental Material - Eperzan

Supplemental Material - Entyvio

Supplemental Material - Deltyba

Supplemental Material - Daklinza

Supplemental Material - Cyramza

Supplemental Material - Cometriq

Supplemental Material - Adempas

Supplemental Material - New Medicines

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014

Supplemental Material - Zydelig

Supplemental Material - Vimizim

Supplemental Material - Velphoro

Supplemental Material - Vargatef

Supplemental Material - Trulicity

Supplemental Material - Translarna

Supplemental Material - Tivicay

Supplemental Material - Tecfidera

Supplemental Material - Sylvant

Supplemental Material - Sovaldi

Supplemental Material - Sirturo

Supplemental Material - Scenesse

Supplemental Material - Rixubris

Supplemental Material - Plegridy

Supplemental Material - Olysio

Supplemental Material - Nuwiq

Supplemental Material - Moventig

Supplemental Material - Mekinist

Supplemental Material - Lynparza

Supplemental Material - Latuda

Supplemental Material - Jardiance

Supplemental Material - Incruse

Supplemental Material - Imbruvica

Supplemental Material - Harvoni

Supplemental Material - Gazyvaro

Supplemental Material - Eperzan

Supplemental Material - Entyvio

Supplemental Material - Deltyba

Supplemental Material - Daklinza

Supplemental Material - Cyramza

Supplemental Material - Cometriq

Supplemental Material - Adempas

Supplemental Material - New Medicines

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date